<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2023-2875</article-id><article-id custom-type="edn" pub-id-type="custom">UZDNTF</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-2875</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group></article-categories><title-group><article-title>Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report</article-title><trans-title-group xml:lang="ru"><trans-title>Хроническая сердечная недостаточность с улучшенной фракцией выброса левого желудочка у пациента с тахииндуцированной кардиомиопатией: клиническое наблюдение</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7114-435X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Правкина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pravkina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Правкина Екатерина Алексеевна</p></bio><bio xml:lang="en"><p>Ekaterina A. Pravkina</p></bio><email xlink:type="simple">vikont313arbus@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5697-271X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кочнова</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kochnova</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кочнова Евгения Николаевна</p></bio><bio xml:lang="en"><p>Evgenia N. Kochnova</p></bio><email xlink:type="simple">kochnova_z@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6141-8994</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Переверзева</surname><given-names>К. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Pereverzeva</surname><given-names>K. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Переверзева Кристина Геннадьевна</p></bio><bio xml:lang="en"><p>Kristina G. Pereverzeva</p></bio><email xlink:type="simple">pereverzevakg@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1394-3791</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Якушин</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakushin</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Якушин Сергей Степанович</p></bio><bio xml:lang="en"><p>Sergey S. Yakushin</p></bio><email xlink:type="simple">ssyakushin@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Рязанский государственный медицинский университет им. акад. И.П. Павлова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ryazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>27</day><month>07</month><year>2023</year></pub-date><volume>19</volume><issue>3</issue><fpage>270</fpage><lpage>276</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Pravkina E.A., Kochnova E.N., Pereverzeva K.G., Yakushin S.S., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Правкина Е.А., Кочнова Е.Н., Переверзева К.Г., Якушин С.С.</copyright-holder><copyright-holder xml:lang="en">Pravkina E.A., Kochnova E.N., Pereverzeva K.G., Yakushin S.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/2875">https://www.rpcardio.online/jour/article/view/2875</self-uri><abstract><p>Heart failure and arrhythmias are pathogenetically closely interconnected and they are mutually aggravating each other. At the same time, tachycardia-induced cardiomyopathy is particularly a reversible disease with proper treatment. This article presents a case report of an elderly patient with hypertension and atrial fibrillation, which are associated to an advanced heart failure and complicating the management of a decreasing kidneys filtration capacity, hematuria and brain stroke. In this case report, tachycardia-induced cardiomyopathy is caused by persistent atrial fibrillation. A complex approach to diagnosis and evidence-based treatment (in particular cardioversion and radiofrequency ablation) made it possible to restore sinus rhythm and compensate heart failure. Dynamics of the clinical state of the patient, laboratory indicators, echocardiographic characteristics allowed us to retrospectively verify atrial fibrillation-mediated cardiomyopathy as the main cause of heart failure progression, and classify this clinical case as heart failure with improved ejection fraction.</p></abstract><trans-abstract xml:lang="ru"><p>Сердечная недостаточность и аритмии патогенетически тесно взаимосвязаны и взаимоотягощают друг друга. При этом тахииндуцированная кардиомиопатия занимает особое место, поскольку является обратимой патологией при соответствующем лечении. Представлено наблюдение пациента пожилого возраста с артериальной гипертензией и фибрилляцией предсердий, сопровождавшимися прогрессирующим нарастанием явлений хронической сердечной недостаточности и осложнявшими его ведение нестабильной фильтрационной функцией почек, гематурией и мозговым инсультом. В данном клиническом случае наличие персистирующей аритмии привело к тахииндуцированной кардиомиопатии. Комплексный подход с применением современных методов обследования и лечения с доказанной эффективностью (в частности, электроимпульсной терапии и радиочастотной аблации) позволил восстановить синусовый ритм и достичь компенсации хронической сердечной недостаточности. Динамика клинического состояния пациента, лабораторных показателей и эхокардиографической картины позволила ретроспективно убедиться в верности предположения о кардиомиопатии, вызванной фибрилляцией предсердий, как основной причине прогрессирования сердечной недостаточности, и классифицировать случай как хроническую сердечную недостаточность с улучшенной фракцией выброса.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность с улучшенной фракция выброса</kwd><kwd>хроническая сердечная недостаточность с восстановленной фракцией выброса</kwd><kwd>тахииндуцированная кардиомиопатия</kwd><kwd>N-терминальный мозговой натрийуретический пропептид</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic heart failure with improved ejection fraction</kwd><kwd>chronic heart failure with recovered ejection fraction</kwd><kwd>tachycardia-induced cardiomyopathy</kwd><kwd>N–terminal pro-brain natriuretic peptide</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021;23(3):352-380. DOI:10.1002/ejhf.2115.</mixed-citation><mixed-citation xml:lang="en">Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Eur J Heart Fail. 2021;23(3):352-380. DOI:10.1002/ejhf.2115.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Merlo M, Caiffa T, Gobbo M, et al. Reverse Remodeling in Dilated Cardiomyopathy. J Am Coll Cardiol. 2011;57(13):1468-76. DOI:10.1016/j.jacc.2010.11.030.</mixed-citation><mixed-citation xml:lang="en">Merlo M, Caiffa T, Gobbo M, et al. Reverse Remodeling in Dilated Cardiomyopathy. J Am Coll Cardiol. 2011;57(13):1468-76. DOI:10.1016/j.jacc.2010.11.030.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Basuray A, French B, Ky B, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014;129(23):23807. DOI:10.1161/CIRCULATIONAHA.113.006855.</mixed-citation><mixed-citation xml:lang="en">Basuray A, French B, Ky B, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014;129(23):23807. DOI:10.1161/CIRCULATIONAHA.113.006855.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: New approaches to diagnosis and management. Clin Cardiol. 2020;43(2):145-155. DOI:10.1002/clc.23321.</mixed-citation><mixed-citation xml:lang="en">Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: New approaches to diagnosis and management. Clin Cardiol. 2020;43(2):145-155. DOI:10.1002/clc.23321.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Huizar JF, Ellenbogen KA, Tan AY, et al. Arrhythmia-induced cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(18):2328-2344. DOI:10.1016/j.jacc.2019.02.045.</mixed-citation><mixed-citation xml:lang="en">Huizar JF, Ellenbogen KA, Tan AY, et al. Arrhythmia-induced cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73(18):2328-2344. DOI:10.1016/j.jacc.2019.02.045.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Albakri A. Tachycardia-induced cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management method. Integr Mol Med. 2018;5:1-13. DOI:10.15761/IMM.1000324.</mixed-citation><mixed-citation xml:lang="en">Albakri A. Tachycardia-induced cardiomyopathy: a review of literature on clinical status and meta-analysis of diagnosis and clinical management method. Integr Mol Med. 2018;5:1-13. DOI:10.15761/IMM.1000324.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fenelon G, Wijns W, Andries E, et al. Tachycardiomyopathy: mechanisms and clinical applications. Pacing Clin Electrophysiol. 1996;19(1):95-106. DOI:10.1111/j.1540-8159.1996.tb04796.x.</mixed-citation><mixed-citation xml:lang="en">Fenelon G, Wijns W, Andries E, et al. Tachycardiomyopathy: mechanisms and clinical applications. Pacing Clin Electrophysiol. 1996;19(1):95-106. DOI:10.1111/j.1540-8159.1996.tb04796.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Чаулин А.М., Дупляков Д. В. Повышение натрийуретических пептидов, не ассоциированное с сердечной недостаточностью. Российский кардиологический журнал. 2020;25(4S):4140 DOI:10.15829/1560-4071-2020-4140.</mixed-citation><mixed-citation xml:lang="en">Chaulin AM, Duplyakov DV. Increased natriuretic peptides not associated with heart failure. Russian Journal of Cardiology. 2020;25(4S):4140 (In Russ.) DOI:10.15829/1560-4071-2020-4140.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579-e646. DOI:10.1161/CIR.0000000000000455.</mixed-citation><mixed-citation xml:lang="en">Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579-e646. DOI:10.1161/CIR.0000000000000455.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Báez Cabanillas MV, Colque R, Tibaldi MÁ, et al. Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy. Drugs Context. 2023;12:2022-8-4. DOI: 10.7573/dic.2022-8-4.</mixed-citation><mixed-citation xml:lang="en">Báez Cabanillas MV, Colque R, Tibaldi MÁ, et al. Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy. Drugs Context. 2023;12:2022-8-4. DOI: 10.7573/dic.2022-8-4.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083. DOI:10.15829/1560-4071-2020-4083.</mixed-citation><mixed-citation xml:lang="en">2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083 (In Russ.) DOI:10.15829/1560-4071-2020-4083.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17):2160-72. DOI:10.1016/j.jacc.2017.02.049.</mixed-citation><mixed-citation xml:lang="en">Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17):2160-72. DOI:10.1016/j.jacc.2017.02.049.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов О.С., Богданова А. А., Щекочихин Д. Ю., и др. Оценка отдаленного прогноза у пациентов с тахикардия-индуцированной кардиомиопатией. Кардиология и сердечно-сосудистая хирургия. 2022;15(5):508-513. DOI:10.17116/kardio202215051508.</mixed-citation><mixed-citation xml:lang="en">Orlov OS, Bogdanova AA, Shchekochikhin DYu, et al. Long-term prognosis in patients with tachycardiainduced cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(5):508–513 (In Russ.) DOI:10.17116/kardio202215051508.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Никулина Н. Н. Актуализация позиций глифлозинов в алгоритмах лечения пациентов с сердечной недостаточностью: хронология успеха. Российский медико-биологический вестник имени академика И. П. Павлова. 2022;30(3):411-421]. DOI:10.17816/PAVLOVJ109598.</mixed-citation><mixed-citation xml:lang="en">Nikulina NN. Actualization of positions of gliflozins in treatment algorithms for patients with heart failure: chronology of success. I. P. Pavlov Russian Medical Biological Herald. 2022;30(3):411–421 (In Russ.) DOI:10.17816/PAVLOVJ109598.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wilcox JE, Fang JC, Margulies KB, et al. Heart failure with recovered left ventricular ejection fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020;76(6):719-734. DOI:10.1016/j.jacc.2020.05.075.</mixed-citation><mixed-citation xml:lang="en">Wilcox JE, Fang JC, Margulies KB, et al. Heart failure with recovered left ventricular ejection fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020;76(6):719-734. DOI:10.1016/j.jacc.2020.05.075.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
